FEATURED ARTICLES
Long-Distance Rare Disease Trials: Why PLL Landed On Australia And New Zealand
Australia and New Zealand had a lot to offer PLL Therapeutics, but speed and savings aren't the only upsides for running its rare disease trial from its European home.
-
How AI Will Reshape Study Start-Up
AI can help study start-up teams move from tracking delays to predicting risks—if human judgment, data quality, and governance stay central.
-
Why ING Feels Different
I’ve attended enough clinical trial conferences to know how similar they can feel. ING is different. Its Dive Teams, WhaleTank, and candid conversations are designed to get attendees participating, not just listening. This year, I’m especially interested in an off-the-record regulatory panel that could tackle some of the biggest changes facing clinical research.
-
From An Empty Building To High-Tech Production
Explore the journey from empty facility to advanced manufacturing hub, covering project execution, team alignment, quality systems, community partnerships, and global expansion.